We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Keith Blundy.
- Abstract
An interview with Keith Blundy, chief executive officer (CEO) of Cancer Research Technology Ltd. (CRT), the development and commercialization arm of the nonprofit organization Cancer Research UK (CRUK), is presented. He discusses the launch and the functions of the antibody discovery and development facility CRUK-MEDI Alliance Laboratory. He explains the importance of early diagnosis and states that CRT has been focusing on multitarget biologic alliances with industry.
- Subjects
BLUNDY, Keith; MEDICAL laboratories; EARLY diagnosis; IMMUNOGLOBULINS; DRUG development; CHIEF executive officers; CANCER Research Technology Ltd.; CANCER Research UK (Organization)
- Publication
Nature Reviews Drug Discovery, 2014, Vol 13, Issue 11, p806
- ISSN
1474-1776
- Publication type
Article
- DOI
10.1038/nrd4480